Brief: Bone Therapeutics Expects Topline Results In Knee Osteoarthritis Study In Q3 2021
22/12/2020 06:04
Dec 22 (Reuters) - BONE THERAPEUTICS SA BOTHE.BR :
* BONE THERAPEUTICS COMPLETES RECRUITMENT AND PATIENT
TREATMENT IN
JTA-004 PIVOTAL PHASE III KNEE OSTEOARTHRITIS STUDY
* TOPLINE RESULTS ARE ANTICIPATED ON 3-MONTH PRIMARY
ENDPOINT AND
6-MONTH FOLLOW-UP PERIOD IN Q3 OF 2021
Source text for Eikon: ID:nGNE9tQG06
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd